StockClub

TGTX

TGTXTG Therapeutics, Inc.$ --
TG Therapeutics, Inc.

TG Therapeutics, Inc.

TGTX

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
193M USD
YoY +78.0%
Operating Income
50M USD
YoY +68.6%
Net Income
23M USD
YoY -1.3%
EPS
0.16$
YoY 0.0%

Revenue

$616.3M
FY2024 Q1$63.5M
$63.5M
Q1
FY2024 Q2$136.9M
$136.9M
Q2
FY2024 Q3$220.8M
$220.8M
Q3
FY2024 Q4$329M
$329M
Q4
FY2025 Q1$120.9M
$120.9M
Q1
FY2025 Q2$262M
$262M
Q2
FY2025 Q3$423.7M
$423.7M
Q3
FY2025 Q4$616.3M
$616.3M
Q4
Actual
+$287.3M (+87.3%)

Net Income

$447.2M
FY2024 Q1$-10.7M
$-10.7M
Q1
FY2024 Q2$-3.8M
$-3.8M
Q2
FY2024 Q3$52,000
$52,000
Q3
FY2024 Q4$23.4M
$23.4M
Q4
FY2025 Q1$5.1M
$5.1M
Q1
FY2025 Q2$33.2M
$33.2M
Q2
FY2025 Q3$424.1M
$424.1M
Q3
FY2025 Q4$447.2M
$447.2M
Q4
Actual
+$423.8M (+1812.4%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$152,000
Est:$168,000
FY2020MISS
$152,000
FY2021MISS
Actual:$6.7M
Est:$7M
FY2021MISS
$6.7M
FY2022MISS
Actual:$2.8M
Est:$4.3M
FY2022MISS
$2.8M
FY2023MISS
Actual:$233.7M
Est:$289.3M
FY2023MISS
$233.7M
FY2024BEAT
Actual:$329M
Est:$321.5M
FY2024BEAT
$329M
FY2025BEAT
Actual:$616.3M
Est:$615.6M
FY2025BEAT
$616.3M

Analyst Estimates